StockData
NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31

NuCana plc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026
$0.98−0.01 (-1.30%)

Close on Oct 19, 2026

NuCana plc revenue by segment

No segment breakdown reported

NuCana does not break out revenue by segment, region or product in the tagged data of its filings for this period type.